What's new

PSUSA/00010856/202408

PSUSA/00010856/202408

Apr 10, 2025 - 15:36
 0
PSUSA/00010856/202408
PSUSA/00010856/202408
Read More

Tags:

Previous Article

These Are Your Dream Car Jobs

Next Article

Human medicines European public assessment report (EPAR): Akynzeo, netupitant,pa...

Related Posts

Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025  0

Call for scientific data for the periodic review of the...

Apr 1, 2025  0

Referral: Mysimba, naltrexone,bupropion Article 20 procedures CHMP opinion, 27/03/2025, 28/03/2025

Referral: Mysimba, naltrexone,bupropion Article 20 proc...

Mar 28, 2025  0